Comparable stake leader
Temasek Holdings (Private) Ltd
SEC ownership of Pear Therapeutics, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001835567.
Disclosed value leader
—
Comparable rows
0/20
Latest evidence
10 Apr 2023
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Temasek Holdings (Private) Ltd
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
10 Apr 2023
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001835567
- Issuer location
- Boston, MA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Pear Therapeutics, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Temasek Holdings (Private...
Disclosed value leader
—
Comparable rows
0/20
Latest evidence
10 Apr 2023
3/4/5
Some rows are evidence-backed but not safely comparable across classes.
20 rows are not safely comparable across share classes.
Showing 1-8 of 20 holder rows.
Quick read
SEC ownership evidence is available, but the rows are not safely comparable across share classes.
0 of 20 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Temasek Holdings (Private) Ltd's linked filing trail.
Detailed SEC evidence table Showing 1-8 of 20 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Temasek Holdings (Private) Ltd |
3/4/5
10%+ Owner
|
—
denominator unverified
|
—
26,803,573 shares
|
— | 03 Dec 2021 |
| Andrew J. Schwab |
3/4/5
Director, 10%+ Owner
|
—
denominator unverified
|
—
18,631,771 shares
|
— | 03 Dec 2021 |
| LJ10 LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
—
6,110,000 shares
|
— | 09 Dec 2022 |
| 5AM Partners IV, LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
—
200,000 shares
|
— | 10 Apr 2023 |
| Zack Lynch |
3/4/5
Director
|
—
mixed-class rows
|
—
10,796,035 shares
mixed-class rows
|
— | 03 Dec 2021 |
| Corey McCann |
3/4/5
President and CEO, Director
|
—
denominator unverified
|
—
2,857,142 shares
|
— | 15 Feb 2023 |
| Guiffre Christopherd T. |
3/4/5
CFO, COO, Treas., & Asst. Sec.
|
—
mixed-class rows
|
—
2,365,174 shares
mixed-class rows
|
— | 15 Feb 2023 |
| Julia Strandberg |
3/4/5
Chief Commercial Officer
|
—
denominator unverified
|
—
1,409,523 shares
|
— | 15 Feb 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
No eligible buy or sell activity is available for this window. No eligible Buy or Sell transactions are available in this dataset since 21 Oct 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 26 reporting-owner rows connected to Pear Therapeutics, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
26
Largest Forms 3/4/5 holder
Henry S. Miller
Net 12M change
$0
Latest report
10 Apr 2023
Recent insider transactions for Pear Therapeutics, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.